In the analysis of the other 18 tumors, we found that compared with the control group, the expression of RAB3B in LUAD, CESC, LIHC, and ESCA increased, while in KIRC and GBM, the expression of RAB3B decreased (Fig. 5B). The gene discussed is RAB3B; the disease is glioblastoma.